Yvonne Brandberg

ORCID: 0000-0001-9840-9266
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer survivorship and care
  • Breast Implant and Reconstruction
  • Cutaneous Melanoma Detection and Management
  • Breast Cancer Treatment Studies
  • BRCA gene mutations in cancer
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Cancer Treatment and Pharmacology
  • Health Systems, Economic Evaluations, Quality of Life
  • Family Support in Illness
  • Cancer-related cognitive impairment studies
  • Skin Protection and Aging
  • Patient-Provider Communication in Healthcare
  • Reconstructive Surgery and Microvascular Techniques
  • Global Cancer Incidence and Screening
  • Childhood Cancer Survivors' Quality of Life
  • HER2/EGFR in Cancer Research
  • Allergic Rhinitis and Sensitization
  • Palliative Care and End-of-Life Issues
  • Advanced Radiotherapy Techniques
  • Behavioral Health and Interventions
  • Ethics in Clinical Research
  • Body Image and Dysmorphia Studies
  • Erythropoietin and Anemia Treatment
  • Lymphatic System and Diseases

Karolinska Institutet
2016-2025

Karolinska University Hospital
2010-2022

Skåne University Hospital
2010-2017

Lund University
2010-2017

Universität Innsbruck
2013

Innsbruck Medical University
2013

Ghent University Hospital
2013

Fondazione IRCCS Istituto Nazionale dei Tumori
2013

Sophiahemmet Hospital
1993-2012

UNSW Sydney
2010

There is increasing recognition of mindfulness and training as a way to decrease stress increase psychological functioning.The aims this study were examine the effects reduction on perceived well-being if changes in mediate intervention these outcomes.Seventy women one man with previous cancer diagnosis (mean age 51.8 years, standard deviation = 9.86) randomized into an group or wait-list control group. The consisted 8-week course.Compared participants group, had significantly decreased...

10.1007/s12160-010-9168-6 article EN Annals of Behavioral Medicine 2010-02-22

PURPOSE: To investigate the effect of recombinant human erythropoietin (epoetin beta) on anemia, transfusion need, and quality life (QOL) in severely anemic patients with low-grade non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), or multiple myeloma (MM). PATIENTS AND METHODS: Transfusion-dependent NHL (n = 106), CLL 126), MM 117) a low serum concentration were randomized to receive epoetin beta 150 IU/kg placebo subcutaneously three times week for 16 weeks. Primary efficacy...

10.1200/jco.2002.08.131 article EN Journal of Clinical Oncology 2002-05-15

To prospectively evaluate body image, sexuality, emotional reactions (anxiety, depression), and quality of life in a sample women having increased risk for breast cancer before 6 months 1 year after bilateral prophylactic mastectomy (BPM), to compare preoperative expectations the operation with postoperative concerning impact on six areas women's lives.A total 90 98 consecutive who underwent BPM during October 1997 December 2005 were included. Data collected by self-administered...

10.1200/jco.2007.13.9568 article EN Journal of Clinical Oncology 2008-08-18

Mastectomy due to breast cancer is associated with chronic pain and a negative impact on sexuality. The purposes of the study were analyze prevalence discomfort in breasts, sexuality, quality life, feelings regret after bilateral prophylactic mastectomy immediate reconstruction implants.Fifty-nine women operated 2004-2006 included. A questionnaire was sent out two years procedure. Complications re-operations recorded.Mean follow-up time 29 months. 93% patients answered questionnaire. 69%...

10.1016/j.breast.2010.05.003 article EN cc-by-nc-nd The Breast 2010-06-04

<h3>Importance</h3> Standard dosing of chemotherapy based on body surface area results in marked interpatient variation pharmacokinetics, toxic effects, and efficacy. Whether tailored can improve outcomes is unknown, as the role dose-dense adjuvant chemotherapy. <h3>Objective</h3> To determine whether improves early breast cancer compared with a standard 3-weekly schedule. <h3>Design, Setting, Participants</h3> A randomized, open-label, phase 3 trial women aged 65 years younger who had...

10.1001/jama.2016.15865 article EN JAMA 2016-11-08

The objective of this study was to assess health status and quality life in macromastia patients undergoing reduction mammaplasty. From January 1997 June 1997, the Department Reconstructive Plastic Surgery, at Stockholm Söder Hospital/Karolinska Hospital, conducted a prospective questionnaire with preoperative postoperative (6 12 months) assessments 49 women who were 20 years or older. included four parts: Part I assessed pain (scale 1 10) neck, shoulders, back, breast, bra strap indention,...

10.1097/00006534-200010000-00005 article EN Plastic & Reconstructive Surgery 2000-10-01

During the last 30 years, many methods for delayed breast reconstruction have been described. There is a lack of prospective randomized trials comparing methods. The present study (SVEA), conducted 1995 to 1996, describes impacts three methods: lateral thoracodorsal flap, latissimus dorsi and pedicled transverse rectus abdominis muscle flap (TRAM), on important areas life, patients' perception cosmetic result, quality life. Questionnaires were completed before randomization at 6 12 months...

10.1097/00006534-200001000-00011 article EN Plastic & Reconstructive Surgery 2000-01-01

The incidence of melanoma continues to increase in many countries, and primary prevention includes avoidance sunburn as well adequate sun protection behavior. aim this study was examine the prevalence self-reported behaviors users Internet, identify demographic, clinical, attitudinal/motivational correlates behaviors.Self-report data were gathered on behalf GenoMEL consortium using an online survey available 10 different languages, 8,178 individuals successfully completed at least 80% items,...

10.1158/1055-9965.epi-10-0196 article EN Cancer Epidemiology Biomarkers & Prevention 2010-09-01

Conventional interferon-alpha (IFN) is an effective treatment for patients with myeloproliferative disorders. However, many discontinue therapy because of side effects.In this 24-month, Phase II feasibility study pegylated interferon alpha-2b (PEG-IFN) treatment, a starting dose 0.5 microg/kg per week was received by 21 polycythemia vera (PV) and essential thrombocythemia (ET). The objective, complete platelet response (CR), count<400x10(9)/L in symptomatic <600 asymptomatic patients....

10.1002/cncr.21900 article EN Cancer 2006-04-25

As patient assessment of health-related quality life (HRQOL) in cancer clinical trials has increased over the years, so need to attach meaningful interpretations differences HRQOL scores between groups and changes within groups. Determining what represents a minimally important difference (MID) is useful clinicians, patients researchers, can be used as benchmark for assessing success healthcare intervention. Our objective provide an evidence-based protocol determine MIDs European...

10.1136/bmjopen-2017-019117 article EN cc-by-nc BMJ Open 2018-01-01

<h3>Importance</h3> Trastuzumab emtansine (T-DM1) is presently approved for treatment of advanced breast cancer and after incomplete response to neoadjuvant therapy, but the potential T-DM1 as monotherapy so far unknown. <h3>Objective</h3> To assess pathologic complete (pCR) standard therapy combination docetaxel, trastuzumab, pertuzumab (DTP) vs in patients with ERBB2 (formerly HER2)-positive cancer. <h3>Design, Setting, Participants</h3> This randomized phase 2 trial, conducted at 9 sites...

10.1001/jamaoncol.2021.1932 article EN JAMA Oncology 2021-06-24

Breast reconstructions after breast cancer surgery are primarily performed to improve patients' quality of life. This study was investigate satisfaction with reconstruction and life pedicled or free transverse rectus abdominis musculocutaneous (TRAM) flap evaluate the aesthetic result both objectively subjectively. Sixty-three patients (36 flaps 27 TRAM flaps) answered two questionnaires; this group, 53 (27 26 participated in an evaluation. The questionnaires consisted parts: one...

10.1097/00006534-200104150-00007 article EN Plastic & Reconstructive Surgery 2001-04-01

Abstract The HAD scale was used to assess anxiety and depressive symptoms in three groups of individuals visiting an oncology clinic, healthy persons with hereditary melanoma (group DNS), patients treated for cutaneous malignant stage I MM1), generalized disease MM2). No differences were found on the subscale, although MM2 scored higher than other two out seven items. depression six items this subscale showed scores groups. In group as compared groups, there a proportion scoring above...

10.1002/pon.2960010204 article EN Psycho-Oncology 1992-07-01

In a prospective, randomized study, an individual psychosocial support intervention performed by specially trained oncology nurses, or psychologists, were compared with standard care. Consecutive primary breast cancer patients about to start adjuvant therapy (n = 179) included. Data supplied the questionnaires European Organisation for Research and Treatment of Cancer Quality Life Study Group Core life questionnaire 30 questions (EORTC QLQ-C30) Breast Module 23 (BR23), Hospital Anxiety...

10.1097/01.ncc.0000270709.64790.05 article EN Cancer Nursing 2007-05-01

Background. Treatment of localized prostate cancer (PC) is controversial. This the first randomized study comparing an open surgery procedure (radical prostatectomy) with a combination high-dose rate brachytherapy (2 × 10 Gy) and external beam radiotherapy (25 2 in PC patients Sweden 1996–2001. The two randomization arms were compared regarding differences patients-reported outcomes, such as complications health-related quality life (HRQoL).

10.3109/0284186x.2014.974827 article EN Acta Oncologica 2014-11-02
Coming Soon ...